The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells.

MEDKOVÁ, Michaela, Pedro FARIA ZENI, L. JANSKÁ, Péter KACZ, Sonali SHARMA, Androniki MICHAELOU, Václav ŠEDA, Lenka KOŠŤÁLOVÁ, Laura ONDRIŠOVÁ, Veronika PALUŠOVÁ, Eva VOJÁČKOVÁ, Daniel FILIP, Josef VEČEŘA, Miroslav BOUDNÝ and Marek MRÁZ. The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells. In PhD and PostDoc RETREAT, Sněžné, Milovy. 2023.

Basic information

• Original name: The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells.
• Authors: MEDKOVÁ, Michaela, Pedro FARIA ZENI, L. JANSKÁ, Péter KACZ, Sonali SHARMA, Androniki MICHAELOU, Václav ŠEDA, Lenka KOŠŤÁLOVÁ, Laura ONDRIŠOVÁ, Veronika PALUŠOVÁ, Eva VOJÁČKOVÁ, Daniel FILIP, Josef VEČEŘA, Miroslav BOUDNÝ and Marek MRÁZ.
• Edition: PhD and PostDoc RETREAT, Sněžné, Milovy, 2023.

Other information

• Type of outcome: Conference abstract
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Central European Institute of Technology

Links

• LX22NPO5102, research and development project: Name: Národní ústav pro výzkum rakoviny (Acronym: NÚVR)

Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES

• MUNI/A/1224/2022, interní kód MU: Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit X

Investor: Masaryk University

• NU22-03-00117, research and development project: Name: MICRORNA REGULACE B-T BUNĚČNÝCH INTERAKCÍ V AGRESIVITĚ A TRANSFORMACI “INDOLENTNÍCH” B BUNĚČNÝCH MALIGNIT
• NU23-08-00448, research and development project: Name: VÝVOJ MODELŮ PRO STUDIUM MIKROPROSTŘEDÍ A TERAPEUTICKÉ REZISTENCE U B BUNĚČNÝCH MALIGNIT

Investor: Ministry of Health of the CR, Development of models for the studies of microenvironment and therapeutic resistance in B cell malignancies, Subprogram 1 - standard

• 802644, interní kód MU: Name: Signaling propensity in the microenvironment of B cell chronic lymphocytic leukemia (Acronym: LeukemiaEnviron)

Investor: European Union, ERC (Excellent Science)